Anaptysbio (ANAB) EBT Margin (2016 - 2026)
Anaptysbio (ANAB) posted EBT Margin of 206.78% for Q1 2026, down 412.07% on a QoQ basis from 66.26% in Q4 2025, and down 6532.0% year-over-year from 3.21% in Q1 2025.
Anaptysbio (ANAB) EBT Margin (2016 - 2026) Analysis & Trends
Anaptysbio's EBT Margin history runs 11 years deep, the most recent figure standing at 206.78% for Q1 2026.
- Quarterly EBT Margin fell 6532.0% year-over-year to 206.78% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.41% (up 16312.0% YoY) and the FY2025 annual result came in at 5.57%, up 15353.0% from the prior year.
- EBT Margin was 206.78% for Q1 2026 at Anaptysbio, down from 66.26% in the prior quarter.
- Across five years, EBT Margin topped out at 66.26% in Q4 2025 and bottomed at 5811.96% in Q1 2022.
- A 5-year average of 1320.1% and a median of 454.36% in 2022 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin plunged 545825 bps — and 2024, when it jumped 394039 bps.
- Anaptysbio's EBT Margin stood at 454.36% in 2022, then retreated by 3 bps to 468.32% in 2023, then jumped by 81 bps to 87.16% in 2024, then surged by 176 bps to 66.26% in 2025, then sank by 412 bps to 206.78% in 2026.
- Business Quant data shows ANAB's EBT Margin at 206.78% in Q1 2026, 66.26% in Q4 2025, and 30.23% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 33.74% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | -206.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.78% |
| Dec 31, 2025 | 66.26% |
| Sep 30, 2025 | 30.23% |
| Jun 30, 2025 | -173.34% |
| Mar 31, 2025 | -141.46% |
| Dec 31, 2024 | -87.16% |
| Sep 30, 2024 | -219.01% |
| Jun 30, 2024 | -425.22% |
| Mar 31, 2024 | -612.01% |
| Dec 31, 2023 | -468.32% |
| Sep 30, 2023 | -1,124.41% |
| Jun 30, 2023 | -1,151.59% |
| Mar 31, 2023 | -4,552.40% |
| Dec 31, 2022 | -454.36% |
| Sep 30, 2022 | -2,909.44% |
| Jun 30, 2022 | -4,200.74% |
| Mar 31, 2022 | -5,811.96% |
| Dec 31, 2021 | -3,177.74% |
| Sep 30, 2021 | -168.43% |
| Jun 30, 2021 | -131.02% |